Today: 19 March 2026
Subscribe
Browse Category

NASDAQ:GRAIL 30 December 2025 - 20 February 2026

GRAIL stock dives nearly 50% after UK Galleri trial misses key goal, raising FDA questions

GRAIL stock dives nearly 50% after UK Galleri trial misses key goal, raising FDA questions

GRAIL shares plunged nearly 50% to $51.00 after a UK trial showed its Galleri blood test missed the main goal of significantly improving early cancer detection. The study’s results complicate prospects for broad screening and reimbursement. Focus now shifts to U.S. regulators and Medicare-linked evidence. GRAIL reported Q4 revenue up 14% to $43.6 million and said its FDA approval submission is under review.
20 February 2026
··
GRAIL stock drops in New York session as Galleri FDA filing timeline returns to focus

GRAIL stock drops in New York session as Galleri FDA filing timeline returns to focus

GRAIL shares dropped 3.3% to $84.95 Tuesday afternoon, extending a two-day slide. An Oregon Health & Science University release highlighted PATHFINDER 2 data and confirmed a first-quarter 2026 FDA submission for Galleri. Investors await management’s Jan. 12 update at the J.P. Morgan Healthcare Conference. The stock is down 7.2% since Friday’s close.
30 December 2025
··

Stock Market Today

  • Specialty Equipment Distributors Q4 Earnings Review: SiteOne, Richardson Electronics, Herc Holdings
    March 19, 2026, 2:32 PM EDT. Specialty equipment distributors showed mixed Q4 results, with revenues beating estimates by 1.4% overall but share prices falling an average of 10.4%. SiteOne (NYSE:SITE) reported $1.05 billion in revenue, up 3.2%, missing estimates by 0.9%, but beating EPS and EBITDA expectations. Its stock dropped 12.9% post-earnings, trading at $129.55. Richardson Electronics (NASDAQ:RELL) posted $52.29 million, up 5.7%, exceeding revenue forecasts by 4.8%, yet its shares fell 7.4% to $10.82. Herc Holdings (NYSE:HRI), specializing in equipment rentals, saw a 27.1% revenue increase to $1.21 billion. Despite solid earnings, the sector faces pressure from economic cycles affecting capital spending and manufacturing, influencing stock performance and growth prospects.
Go toTop